000 01331 a2200397 4500
005 20250516153152.0
264 0 _c20140124
008 201401s 0 0 eng d
022 _a2157-1422
024 7 _a10.1101/cshperspect.a011767
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlivieri, Nancy F
245 0 0 _aManagement of the thalassemias.
_h[electronic resource]
260 _bCold Spring Harbor perspectives in medicine
_cJun 2013
500 _aPublication Type: Journal Article; Review
650 0 4 _aBenzoates
_xeconomics
650 0 4 _aBlood Transfusion
650 0 4 _aDeferasirox
650 0 4 _aDeferiprone
650 0 4 _aDeferoxamine
_xeconomics
650 0 4 _aFerritins
_xblood
650 0 4 _aHumans
650 0 4 _aIron
_xmetabolism
650 0 4 _aIron Chelating Agents
_xeconomics
650 0 4 _aIron Overload
_xtherapy
650 0 4 _aLiver
_xmetabolism
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aPancreas
_xmetabolism
650 0 4 _aPituitary Gland, Anterior
_xmetabolism
650 0 4 _aPyridones
_xeconomics
650 0 4 _aThalassemia
_xtherapy
650 0 4 _aTriazoles
_xeconomics
700 1 _aBrittenham, Gary M
773 0 _tCold Spring Harbor perspectives in medicine
_gvol. 3
_gno. 6
856 4 0 _uhttps://doi.org/10.1101/cshperspect.a011767
_zAvailable from publisher's website
999 _c22804570
_d22804570